Active Recombinant Human TNFRSF21 Protein, Fc Chimera

• Cat.No.: TNFRSF21-1038H
• Product Overview: Recombinant Human TNFRSF21 (Accession # O75509), fused with , was produced in Spodoptera frugiperda, Sf 21 (baculovirus)-derived.

Specification

• Species: Human
• Source: Sf21 Cells
• Tag: Fc
• Predicted N Terminal: Gln42
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its binding ability in a functional ELISA.When recombinant human APP770 is coated at 2 µg/mL (100 µL/well), the concentration of Recombinant Human DR6/TNFRSF21 that produces 50% of the optimal binding response is found to be approximately 20 - 100 ng/mL.
• Molecular Mass: Recombinant Human TNFRSF21, Fc Chimera has a calculated MW of 60.3 kDa (monomer). In SDS-PAGE migrates as 65-75 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: TNFRSF21 tumor necrosis factor receptor superfamily, member 21 [ Homo sapiens ]
• Official Symbol: TNFRSF21
• Synonyms: TNFRSF21; tumor necrosis factor receptor superfamily, member 21; tumor necrosis factor receptor superfamily member 21; CD358; death receptor 6; DR6; TNFR-related death receptor 6; BM-018; MGC31965
• Gene ID: 27242
• mRNA Refseq: NM_014452
• Protein Refseq: NP_055267
• MIM: 605732
• UniProt ID: O75509
• Chromosome Location: 6p21.1